This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Institut Pasteur. Active years: 2011-2017.
Company Filing History:
Years Active: 2011-2017
Title: Evelyne Dufour: Innovator in Pharmaceutical Compositions
Introduction
Evelyne Dufour is a notable inventor based in Vanves, France. She has made significant contributions to the field of pharmaceuticals, particularly through her work on peptides derived from human Basic Proline-rich Lacrimal Protein (BPLP). With a total of 4 patents, her innovations have the potential to impact medical diagnostics and pain treatment.
Latest Patents
Dufour's latest patents include groundbreaking methods for prognosis and diagnosis involving BPLP. One of her inventions focuses on pharmaceutical compositions containing peptides derived from human BPLP protein. This invention relates to an in vitro method for determining the evolution of conditions associated with altered BPLP production. By detecting or quantifying BPLP protein or its maturation products in biological samples, her method allows for comparisons with control subjects. Another significant patent addresses methods for treating pain by administering these peptides, further showcasing her innovative approach to medical challenges.
Career Highlights
Throughout her career, Evelyne Dufour has worked with prestigious organizations, including the Institut Pasteur. Her experience in such esteemed institutions has contributed to her expertise in the field of pharmaceutical research and development.
Collaborations
Dufour has collaborated with notable colleagues, including Catherine Rougeot and Jean-Francois Huaulme. These partnerships have likely enriched her research and expanded the impact of her inventions.
Conclusion
Evelyne Dufour stands out as an influential inventor in the pharmaceutical industry. Her work on BPLP-derived peptides demonstrates her commitment to advancing medical science and improving patient outcomes.